These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 28443468)

  • 41. Curcumin sensitizes human lung cancer cells to apoptosis and metastasis synergistically combined with carboplatin.
    Kang JH; Kang HS; Kim IK; Lee HY; Ha JH; Yeo CD; Kang HH; Moon HS; Lee SH
    Exp Biol Med (Maywood); 2015 Nov; 240(11):1416-25. PubMed ID: 25716014
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Integrated microRNA and gene expression profiling reveals the crucial miRNAs in curcumin anti-lung cancer cell invasion.
    Zhan JW; Jiao DM; Wang Y; Song J; Wu JH; Wu LJ; Chen QY; Ma SL
    Thorac Cancer; 2017 Sep; 8(5):461-470. PubMed ID: 28660665
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Calpain-2 Enhances Non-Small Cell Lung Cancer Progression and Chemoresistance to Paclitaxel via EGFR-pAKT Pathway.
    Xu F; Gu J; Lu C; Mao W; Wang L; Zhu Q; Liu Z; Chu Y; Liu R; Ge D
    Int J Biol Sci; 2019; 15(1):127-137. PubMed ID: 30662353
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Maackia amurensis agglutinin induces apoptosis in cultured drug resistant human non-small cell lung cancer cells.
    Chhetra Lalli R; Kaur K; Chakraborti A; Srinivasan R; Ghosh S
    Glycoconj J; 2019 Dec; 36(6):473-485. PubMed ID: 31758295
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relation between prognosis and expression of metastasis-associated protein 1 in stage I non-small cell lung cancer.
    Yu Y; Wang Z; Zhang MY; Liu XY; Zhang H
    Interact Cardiovasc Thorac Surg; 2011 Feb; 12(2):166-9. PubMed ID: 20935042
    [TBL] [Abstract][Full Text] [Related]  

  • 46. New role of (-)-epicatechin in enhancing the induction of growth inhibition and apoptosis in human lung cancer cells by curcumin.
    Saha A; Kuzuhara T; Echigo N; Suganuma M; Fujiki H
    Cancer Prev Res (Phila); 2010 Aug; 3(8):953-62. PubMed ID: 20606042
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Potential Role of microRNA-183 as a Tumor Suppressor in Hepatocellular Carcinoma.
    Bian W; Zhang H; Tang M; Zhang S; Wang L; Liu L; Wang W
    Cell Physiol Biochem; 2018; 51(5):2065-2072. PubMed ID: 30522116
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of curcumin-inhibited extracellular matrix receptors in non-small cell lung cancer A549 cells by RNA sequencing.
    Li H; Wu H; Zhang H; Li Y; Li S; Hou Q; Wu S; Yang SY
    Tumour Biol; 2017 Jun; 39(6):1010428317705334. PubMed ID: 28618934
    [TBL] [Abstract][Full Text] [Related]  

  • 49. PTD modified paclitaxel anti-resistant liposomes for treatment of drug-resistant non-small cell lung cancer.
    Ju RJ; Cheng L; Xiao Y; Wang X; Li CQ; Peng XM; Li XT
    J Liposome Res; 2018 Sep; 28(3):236-248. PubMed ID: 28480778
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Knockdown of miR‑935 increases paclitaxel sensitivity via regulation of SOX7 in non‑small‑cell lung cancer.
    Peng B; Li C; Cai P; Yu L; Zhao B; Chen G
    Mol Med Rep; 2018 Sep; 18(3):3397-3402. PubMed ID: 30066948
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The relationship between miR-17-5p, miR-92a, and let-7b expression with non-small cell lung cancer targeted drug resistance.
    Gong J; He L; Ma J; Zhang J; Wang L; Wang J
    J BUON; 2017; 22(2):454-461. PubMed ID: 28534369
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Upregulation of miR-34c after silencing E2F transcription factor 1 inhibits paclitaxel combined with cisplatin resistance in gastric cancer cells.
    Zheng H; Wang JJ; Yang XR; Yu YL
    World J Gastroenterol; 2020 Feb; 26(5):499-513. PubMed ID: 32089626
    [TBL] [Abstract][Full Text] [Related]  

  • 53. p38 MAPK-induced MDM2 degradation confers paclitaxel resistance through p53-mediated regulation of EGFR in human lung cancer cells.
    Park SH; Seong MA; Lee HY
    Oncotarget; 2016 Feb; 7(7):8184-99. PubMed ID: 26799187
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Novel ADAM-17 inhibitor ZLDI-8 inhibits the proliferation and metastasis of chemo-resistant non-small-cell lung cancer by reversing Notch and epithelial mesenchymal transition in vitro and in vivo.
    Lu HY; Zu YX; Jiang XW; Sun XT; Liu TY; Li RL; Wu Q; Zhang YS; Zhao QC
    Pharmacol Res; 2019 Oct; 148():104406. PubMed ID: 31442576
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MicroRNA-630 inhibitor sensitizes chemoresistant ovarian cancer to chemotherapy by enhancing apoptosis.
    Eoh KJ; Lee SH; Kim HJ; Lee JY; Kim S; Kim SW; Kim YT; Nam EJ
    Biochem Biophys Res Commun; 2018 Mar; 497(2):513-520. PubMed ID: 29452092
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Up-regulation of miR-146a increases the sensitivity of non-small cell lung cancer to DDP by downregulating cyclin J.
    Shi L; Xu Z; Wu G; Chen X; Huang Y; Wang Y; Jiang W; Ke B
    BMC Cancer; 2017 Feb; 17(1):138. PubMed ID: 28202053
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression of MTA1 promotes motility and invasiveness of PANC-1 pancreatic carcinoma cells.
    Hofer MD; Menke A; Genze F; Gierschik P; Giehl K
    Br J Cancer; 2004 Jan; 90(2):455-62. PubMed ID: 14735193
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synergistic Roles of Curcumin in Sensitising the Cisplatin Effect on a Cancer Stem Cell-Like Population Derived from Non-Small Cell Lung Cancer Cell Lines.
    Abdul Satar N; Ismail MN; Yahaya BH
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33670440
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Down-regulation of MTA1 protein leads to the inhibition of migration, invasion, and angiogenesis of non-small-cell lung cancer cell line.
    Li S; Tian H; Yue W; Li L; Gao C; Si L; Li W; Hu W; Qi L; Lu M
    Acta Biochim Biophys Sin (Shanghai); 2013 Feb; 45(2):115-22. PubMed ID: 23343746
    [TBL] [Abstract][Full Text] [Related]  

  • 60. microRNA-381 suppresses the growth and increases cisplatin sensitivity in non-small cell lung cancer cells through inhibition of nuclear factor-κB signaling.
    Huang RS; Zheng YL; Zhao J; Chun X
    Biomed Pharmacother; 2018 Feb; 98():538-544. PubMed ID: 29287202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.